Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 3
2016 pubmed 36 citations

Gene electrotransfer into skin using noninvasive multi-electrode array for vaccination and wound healing.

Kos. Spela S; Vanvarenberg. Kevin K; Dolinsek. Tanja T; Cemazar. Maja M; Jelenc. Jure J; Préat. Véronique V; Sersa. Gregor G; Vandermeulen. Gaëlle G

Key Findings

  • A non‑invasive multi‑electrode array can deliver plasmid DNA into mouse skin efficiently
  • Plasmid‑encoded LL‑37 (hCAP‑18) accelerates wound closure in mice
  • The same platform can deliver a DNA vaccine and trigger strong immune responses

Practical Outcomes

  • The main takeaway is that skin gene delivery of LL‑37 can boost healing, but the technique requires lab‑grade equipment and plasmids, so it isn’t a DIY protocol today. It points to future non‑invasive gene‑therapy approaches for wound care that biohackers might watch for as the technology matures.

Summary

Scientists made a skin‑friendly electrode pad that can shoot DNA into the skin without needles. Using it, they got mice to make the antimicrobial peptide LL‑37 inside their skin, which made wounds close faster, and they also showed it works for DNA vaccines. The study shows the concept works, but it needs special gear and isn’t ready for home use yet.

Abstract

Skin is an attractive target for gene electrotransfer due to its easy accessibility and its interesting immune properties. Since electrodes are often invasive and frequently induce discomfort during pulse application, there is a fundamental need for non-invasive electrodes for skin delivery. We developed circular pin non-invasive multi-electrode array (MEA), suitable for different clinical applications. MEA was first employed to deliver a luciferase reporter gene. Then, it was used to deliver a DNA vaccine coding for ovalbumin or a plasmid encoding hCAP-18/LL-37 for promoting wound healing. The results demonstrated a strong gene expression and an efficient delivery of both, DNA vaccine and wound healing agent, dependent on the pulses applied. The use of MEA to deliver the ovalbumin plasmid demonstrated a strong immune response, as evidenced by the presence of antibodies in sera, the IFN-gamma response and the delayed tumor growth when the mice were subsequently challenged with B16-OVA cells. The delivery of a plasmid encoding hCAP-18/LL-37 significantly accelerated wound closure. The easy applicability and non-invasiveness of MEA make it suitable for various clinical applications that require gene electrotransfer to skin. Specifically, by adapting electric pulses to the expected action of a transgene, non-invasive MEA can be employed either for vaccination or for wound healing.

Study Information

Provider

pubmed

Year

2016

Date

2016-12-10T00:00:00.000Z

DOI

10.1016/j.bioelechem.2016.12.002

Citations

36

References

29